Pancreatic Cancer Research

ResearcherUNSW SydneyActive in the last 2 years

Hamid Alinejad‐Rokny

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2189-9153; OpenAlex author ID A5019852514. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. PLXDC1+ Tumor-Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202415756↗
  2. Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer. Last author DOI 10.3390/cancers13174376↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Youqiong Ye · 1 shared paper, 2025 · strength 0.22
  2. Yanhua Du · 1 shared paper, 2025 · strength 0.22
  3. Ju‐Dong Li · 1 shared paper, 2025 · strength 0.22
  4. Duowu Zou · 1 shared paper, 2025 · strength 0.22
  5. Chenghao Shao · 1 shared paper, 2025 · strength 0.22
  6. Amin Ghareyazi · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.